CSIR Central

A novel recombinant Leishmania donovani p45, a partial coding region of methionine aminopeptidase, generates protective immunity by inducing a Th1 stimulatory response against experimental visceral leishmaniasis

IR@CDRI: CSIR-Central Drug Research Institute, Lucknow

View Archive Info
 
 
Field Value
 
Creator Gupta, Reema
Kushawaha, P K
Tripathi, C D P
Sundar, Shyam
Dube, Anuradha
 
Date 2012-10-03T11:54:49Z
2012-10-03T11:54:49Z
2012
 
Identifier International Journal for Parasitology , 2012, 42, (5), 429–435
http://hdl.handle.net/123456789/923
 
Description The development of a vaccine against visceral leishmaniasis (VL) conferring long-lasting immunity remains a challenge. Identification and proteomic characterization of parasite proteins led to the detection of p45, a member of the methionine aminopeptidase family. To our knowledge the present study is the first known report that describes the molecular and immunological characterization of p45. Recombinant Leishmania donovani p45 (rLdp45) induced cellular responses in cured hamsters and generated Th1-type cytokines from peripheral blood mononuclear cells of cured/endemic VL patients. Immunization with rLdp45 exerted considerable prophylactic efficacy (~85%) supported by an increase in mRNA expression of iNOS, IFN-γ, TNF-α and IL-12 and decrease in TGF-β and IL-4, indicating its potential as a vaccine candidate against VL.
 
Format 1562191 bytes
application/pdf
 
Language en
 
Relation CDRI Communication No. 8215
 
Subject Leishmania donovani
Recombinant p45
Methionine aminopeptidase
Immunogenicity
T-cell response
Cured Leishmania hamsters
Cured Leishmania patients
Endemic contacts
Prophylactic potential
 
Title A novel recombinant Leishmania donovani p45, a partial coding region of methionine aminopeptidase, generates protective immunity by inducing a Th1 stimulatory response against experimental visceral leishmaniasis
 
Type Article